Table 1.
Binding characterization of DARPin 8h6 to human and mouse CatB as determined by enzyme inhibition (Fig. 1c and Fig. S4) and surface plasmon resonance (Figs. S5, 6).
Inhibition | SPR | ||||||
---|---|---|---|---|---|---|---|
Ki [pM] | α | β | ka [M-1 s-1] | kd [s-1] | KD [nM] | χ2 [%Rmax] | |
Human CatB | 34 ± 1 | 6.6 | 0.15 | 2.1 × 106 | 6.6 × 10-5 | 0.031 | 2.2 % |
Mouse CatB | 35 ± 3 | 6.1 | 0.064 | 7.5 × 105 | 1.5 × 10-4 | 0.20 | 12.5 % |
Human proCatB | 1.4 × 104 | 1.0 × 10-4 | 7.1 | 3.6 % |